Hong Kong Stock Afternoon Review | The three major indices rose, and TechNet stocks strengthened, Ali rose nearly 7%; some domestic housing stocks rose, and Sunac China rose more than 9%
Photovoltaic solar energy stocks weakened, Follett Glass fell nearly 9%, and Xinyi Solar fell more than 8%; insurance stocks generally rose; China Taibao rose more than 2%, and China Life Insurance rose nearly 2%.
Express News | CITIC Construction Investment: The national biotechnology and biomanfacture action plan is expected to be introduced in the near future, and the subsequent implementation of the policy is worth looking forward to
Legend Biotech's Loss Narrows in Q1 as Revenue Surges
Genscript Biotech's (HKG:1548) Nasdaq-listed subsidiary Legend Biotech reported a loss of $59.8 million, or $0.16 per share, in the first quarter, down from $112.1 million, or $0.34 per share, a year
Hong Kong Stock Afternoon Review | Tech Index rose nearly 1%, TechNet stocks and biotech stocks rose higher, Bilibili rose more than 6%, and Laikai Pharmaceuticals rose more than 12%
Auto stocks rose more than 6%; Great Wall Motor rose more than 6%; NIO and Zero Sports Auto rose more than 5%; many coal stocks fell sharply, Yankuang Energy fell more than 6%, and Shougang resources fell nearly 6%.
Intraday Overview | Tech Index rose more than 1%, and TechNet stocks were trending strongly. Bilibili rose more than 6%; Tencent Music rose more than 9% after its performance
Technology Network stocks rose collectively, with Bilibili up more than 6%, Kuaishou and Xiaomi Group up more than 3%; auto stocks improved, Great Wall Motor rose more than 7%, NIO rose nearly 6%, and Zero Sports Auto rose nearly 5%.
Express News | Galaxy Securities: Judging from the pace of the industry's revenue growth rate, the first quarter of 2024 is expected to be the lowest point in the pharmaceutical industry in the whole year
Featured announcements | Tencent Music's adjusted net profit increased by 23.9%; King's Rui: Legendary Biotech's net loss narrowed
China Life Insurance: The cumulative original premium income for the first 4 months was about 371.2 billion yuan, an increase of 3.9% over the previous year; China Resources Land: The cumulative contract sales amount for the first 4 months was approximately RMB 72.0 billion.
Hong Kong Stock Announcement Nuggets | Tencent Music-SW Announces First-Quarter Results Net Profit attributable to equity holders of 1.42 billion yuan, up 23.9% year-on-year
China Resources Land (01109)'s cumulative contract sales amount for the first 4 months was about 72 billion yuan; China Life Insurance (02628)'s original insurance premium income for the first 4 months was about 371.2 billion yuan, up 3.9% year-on-year
Kingsley Biotechnology (01548.HK): Legendary Biotech's total revenue in the first quarter was 93.991 million US dollars, up 158.67% year-on-year
Kingsley Biotech (01548.HK) announced Legendary Biotech's results for the first quarter of 2024, with total revenue of US$93.91 million, up 158.67% year on year; ordinary equity holders of the parent company should have accounted for a loss of US$597.93 million, a year-on-year narrowing of 46.66%; loss per share was US$0.16.
Kingsley Biotechnology (01548): Legendary Biotech's total revenue in the first quarter was 93.991 million US dollars, up 158.67% year-on-year
Kingsley Biotech (01548) announced Legendary Biotech's results for the first quarter of 2024, with total revenue of US$93.91 million, an increase of 158.67%; ordinary equity holders of the parent company should have accounted for a loss of US$597.93 million, a year-on-year narrowing of 46.66%; and a loss of US$0.16 per share.
GENSCRIPT BIO: OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2024 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
A quick look at the Hong Kong market | The three major indices have risen one after another. Technology Network stocks and power stocks are popular. Bilibili has risen more than 6%, and Huadian International has risen nearly 8%
Biotech stocks had mixed ups and downs. Pharmaceutical and Ming Union fell%, and Jinxin Fertility rose%; shipping stocks rose, with Dongfang Overseas International, COSCO Marine Control, and COSCO Marine Energy up nearly 6%.
Intraday quick overview | The Science Index rose more than 1% to reach the 4,000 mark; port transport stocks were strong, and COSCO Marine Control rose more than 6%
Water stocks soared across the board. China Water Services rose more than 9%, Beijing Water Group rose more than 8%; high-speed rail infrastructure stocks collectively rallied, CRRC rose more than 9%, and Times Electric rose nearly 7%.
The medical news is huge! Will Pharmacokinetics usher in a turning point? US pharmaceutical company contract exemption or extension for 8 years
Industry insiders believe that 8 years is enough time for relevant companies to adapt, and the implementation of this greatest uncertainty can also have a positive impact on related companies.
Hong Kong Stock Afternoon Review | The three major indices rose sharply, domestic housing stocks and biotech stocks strengthened, Shimao Group rose more than 42%, and Ziding Pharmaceutical rose nearly 17%
Science and network stocks generally rose; Meituan rose more than 4%, and Bilibili rose nearly 3%; shipping stocks generally rose, with COSCO Maritime Control rising by more than 6%, and Orient Overseas International rising more than 5%.
A quick look at the Hong Kong market | The three major indices have collectively pulled back, and the science index fell more than 2% to 4,000 points; domestic housing stocks rose against the market, and Xincheng Development rose nearly 6%
Technology Network stocks generally fell; Bilibili fell more than 6%, Kuaishou fell nearly 5%, and Meituan fell nearly 4%; copper concept stocks strengthened, Wanguo International Mining rose nearly 10%, and China's nonferrous mining industry rose more than 4%.
Hong Kong Stock Afternoon Review | The three major indices of Hong Kong stocks pulled back, and the Tech Index fell nearly 2%; PV stocks reversed the market, and GCL Technology rose more than 6%
Technology Network stocks declined; Bilibili fell more than 6%, NetEase fell more than 4%, Kuaishou and Meituan fell nearly 4%; as concept stocks declined, Huazhu Group fell more than 3%, and Jiumaojiu fell nearly 3%.
Agency: The synthetic biology sector showed a high increase in Q1 performance, and policy expectations accelerated valuation repair
Currently, the core competitiveness of biological manufacturing companies lies in product development and implementation capabilities. They are optimistic about targets with successful cases, leading positions, high-quality product reserves, and a boom in downstream demand.
Intraday Overview | The three major indices of Hong Kong stocks weakened slightly, and the pharmaceutical outsourcing concept rose against the market
Road transport stocks strengthened; Guangzhou-Shenzhen Railway shares rose more than 9%, Anhui Wantong Expressway rose more than 6%; domestic housing stocks collectively pulled back, Agile Group fell more than 6%, and Midea Real Estate fell more than 5%.
The CXO sector of Hong Kong stocks strengthened collectively: Zhaoyan Pharmaceutical rose nearly 7%, and Kingsley rose more than 5%
Glonghui, May 6 | Hong Kong pharmaceutical stocks rose as a whole. Among them, innovative drugs and CXO showed the most prominent performance. In terms of individual CXO stocks, Zhaoyan Pharmaceutical, Kanglong Chemical, Pharmaceutical and Tiger Pharmaceuticals rose more than 6%, Kingsley rose more than 5%, Gloria Ying rose nearly 5%, and Pharmaceutical Kangde rose more than 3%.
No Data